Details

Autor(en) / Beteiligte

• Schranz, Asher J
• Meisner, Jessica A

Titel

Linking prescription opioids and infectious diseases

Ist Teil von

• The Lancet infectious diseases, 2020-04, Vol.20 (4), p.392-394

Ort / Verlag

United States: Elsevier Ltd

Erscheinungsjahr

2020

Quelle

Elsevier ScienceDirect Journals Complete

Beschreibungen/Notizen

• [...]in a previous study,7 the authors showed that the technique needed to prepare controlled-release hydromorphone for injection led to increased contamination with S aureus. [...]unlike other opioids, controlled-release hydromorphone appears to uniquely support the growth of S aureus, similar to the case of T's and blues and P aeruginosa O11.7 Within efforts to address the current opioid crisis, there has been great interest in so-called abuse-deterrent formulations, which discourage injection via diverse mechanisms. More broadly, supply-side strategies to stem opioid prescribing could lead to a shift from prescription drug use to non-prescription opioids, such as heroin and fentanyl, and in turn an increase in fatal overdoses.9 To fully reduce drug-related harms, these interventions need to be coupled with efforts to build treatment capacity for substance use disorders and to implement harm reduction services, such as syringe exchange programmes.